Beginner view — everything explained simply.
VIP (Vasoaktives Intestinales Peptid)
A natural messenger peptide researched above all for the lungs — but the human study results are mixed
In 10 seconds
VIP is a tiny protein your body makes itself, among other places in nerves, lungs and gut. It widens blood vessels and dampens inflammation. The lab-made drug form is called Aviptadil and was tested in real clinical studies, for example in severe COVID-19 and a rare lung high-pressure condition — with mixed, partly disappointing data.
What is it, really?
Picture a natural go-between that has a say in many places. VIP (Vasoactive Intestinal Peptide) is made of 28 building blocks and acts like a switch that relaxes blood vessels and dials the immune system down a bit. It was first found in the gut — hence "intestinal" — but it occurs throughout the body. In the lab it's rebuilt as the drug Aviptadil and in studies mostly given through a vein or by inhaling — under medical supervision.
In pictures
Structure
A chain built from amino acids
Target area
Lungs, vessels & inflammation
Evidence
Animal studies
Human studies
Real clinical studies in humans exist — but the results are mixed to disappointing, and a proven benefit is not established
What fans report
Claims — not proof
- Supposed to help with severe lung diseases like COVID-19 (a claim much discussed during the pandemic)
- Supposed to dampen inflammation in the body and balance the immune system (online claim)
- Traded in longevity circles as an anti-aging and regeneration agent
The reality check
What the facts say
- VIP/Aviptadil is not a broadly approved medicine but an investigational substance — tested in studies, but without an established standard approval.
- In the rare lung high-pressure condition it showed only a small, temporary effect; controlled studies found no convincing sustained benefit.
- In COVID-19/ARDS the study results are inconsistent and its value is disputed.
- The substance acts on the circulation (widens vessels) — that can lower blood pressure and is hard to control without medical monitoring.
- Vials sold as "research" goods are not quality-tested: purity, sterility and content are unknown.
Risk assessment
VIP is body-own, but as a circulation-active vessel widener with a very short duration of action it was given in studies only under medical control — self-application with unverified grey-market goods is hard to steer.
Legal status: In clinical trials only · not approved
Bottom line
VIP is an intriguing natural messenger that is being seriously researched — but exactly where people expected the most (lungs, COVID-19), the human results fell short of the hopes. It's an investigational substance for science, not a finished product for self-application.
No buying · No dosing · Just knowledge
This page informs — it is no substitute for medical advice. If this topic affects you, talk to a doctor.
Why safety matters